Quick Answer
ANAPTYSBIO, INC reported Diluted EPS of $0.46 per share (loss) for fiscal year 2025.
ANAPTYSBIO, INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.46 | +91.0% |
| 2024 | -$5.12 | +15.8% |
| 2023 | -$6.08 | -33.0% |
| 2022 | -$4.57 | -116.6% |
| 2021 | -$2.11 | -189.0% |
| 2020 | -$0.73 | +79.7% |
| 2019 | -$3.60 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.52 | +145.6% | +138.8% |
| June 30, 2025 | -$1.34 | +21.6% | -4.7% |
| March 31, 2025 | -$1.28 | +22.0% | -12.3% |
| September 30, 2024 | -$1.14 | +19.1% | +33.3% |
| June 30, 2024 | -$1.71 | -14.0% | -4.3% |
| March 31, 2024 | -$1.64 | -3.8% | -16.3% |
| September 30, 2023 | -$1.41 | -19.5% | +6.0% |
| June 30, 2023 | -$1.50 | -30.4% | +5.1% |
- ANAPTYSBIO, INC showed an increase of +91.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, ANAPTYSBIO, INC’s diluted eps has grown by 87.2% (from $3.60 per share (loss) to $0.46 per share (loss)).
- The most recent figure is from ANAPTYSBIO, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: